Ocim Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
as on 26-07-2024
- Paid Up Capital ₹ 4.10 M
as on 26-07-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.44 Cr
as on 26-07-2024
- Revenue -99.26%
(FY 2023)
- Profit 105.25%
(FY 2023)
- Ebitda 63.94%
(FY 2023)
- Net Worth 1.23%
(FY 2023)
- Total Assets -12.38%
(FY 2023)
About Ocim Life Sciences
The Company is engaged in the Consumer Electronics & Durables Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.10 M and a paid-up capital of Rs 4.10 M.
The company currently has active open charges totaling ₹11.44 Cr.
Pankaj Thaneja, Kulveer Chandi, and Gaurav Goyal serve as directors at the Company.
- CIN/LLPIN
U24232RJ2011PTC034219
- Company No.
034219
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ocim Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Thaneja  | Director | 17-Feb-2011 | Current |
| Kulveer Chandi | Director | 18-Nov-2013 | Current |
| Gaurav Goyal | Director | 17-Feb-2011 | Current |
Financial Performance of Ocim Life Sciences.
Ocim Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.26% decrease. The company also saw a substantial improvement in profitability, with a 105.25% increase in profit. The company's net worth moved up by a moderate rise of 1.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ocim Life Sciences?
In 2023, Ocim Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Mar 2021 | ₹3.25 Cr | Open |
Tata Capital Financial Services Limited Creation Date: 25 Oct 2018 | ₹1.00 Cr | Open |
Others Creation Date: 28 Oct 2014 | ₹5.00 Cr | Open |
How Many Employees Work at Ocim Life Sciences?
Unlock and access historical data on people associated with Ocim Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ocim Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ocim Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
